Cholera Toxin, Vibrio cholerae, Inaba 569B

Catalog No : USB-215932
593.12€
0.00€

Shipping cost plus VAT not included , delivery in 7-14 business days

Product name Cholera Toxin, Vibrio cholerae, Inaba 569B
Catalog No USB-215932
Supplier’s Catalog No 215932
Supplier US Biologicals
Source antigen Vibrio cholerae, Inaba 569B
Reactivity
Cross reactivity
Applications
Molecular weight
Storage 4°C Do Not Freeze
Other names
Grade Purified
Purity Purified
Form Supplied as a lyophilized powder in 0.05M Tris, pH 7.5, 0.2M sodium chloride, 0.001M EDTA Na2. No preservative added. Reconstitute with 500ul sterile ddH2O. Handle Gently. Do not vortex.
Reactivity life 12 months
Note For reserch purpose only
Purity Purified
Description Produced by Vibrio cholerae, cholera toxin (CT) is a multimeric enterotoxin that transfers ADP-ribose to a G protein, locking adenyl cyclase in an 'on' position. By binding to the membrane of enteric cells, cholera toxin stimulates the cellular adenylate cyclase system, causing the hyper-secretion of chloride and bicarbonate ions, which results in increased fluid secretion and the severe diarrhea characteristic of the disease cholera. The pentameric B subunit of CT binds with high efficiency to GM1 monosialoganglioside cell membrane receptors, present in many cell types, allowing its use experimentally in cell culture. Following binding, the toxin is endocytosed and travels retrogradely to the endoplasmic reticulum where the enzymatically active A subunit (CTA1) is translocated to the cytosol. Within the cytosol, CTA1 catalyzes the ADP-ribosylation of the Gs protein, activating adenylate cyclase and as a consequence increasing the intracellular concentration of cAMP. Relevant to the development of vaccine adjuvants, CT effectively modulates mammalian immune systems and acts as an adjuvant for co-administered antigens. Source: Cholera Toxin from Vibrio cholerae, Inaba 569B Endotoxin: 8EU/mg (Kinetic Chromagenic LAL assay) Activity: Using trisialoganglioside fixed sheep red blood cells, this lot exhibited strong hemagglutination activity when examined in a modification of Sato, et.et. Storage and Stability: Lyophilized powder may be stored at 4°C. Reconstitute with sterile ddH2O. Aliquot to avoid repeated freezing and thawing. Store at 4°C. Reconstituted product is stable for 6 months at 4°C. For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap. Further dilutions can be made in assay buffer.